JESSICA ENYEART: Open Payments
NPI 1720650849 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$73 in 4 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $21 · 2025 $73
Food & beverage: $73
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Phadia US Inc. | 1 | $17 |
Products named: REXULTI, AUSTEDO XR, ImmunoCAP.
Industry payments across AZ — which companies pay providers there.
